|
Click link below for the (2010) Standpoint Research five-page PDF Presentation
|
| Performance Summary |
Standpoint Research is currently ranked risk-adjusted at # 7 versus 190 funds and research firms according to Motley Fool, Briefing.com & Yahoo! Finance through September 15, 2011. They have a formula in place that factors in performance (two-thirds weight) and accuracy (one-third weight), where accuracy is defined as the percentage of recommendations beating the S&P-500 by at least 500 basis points. They have been tracking us since October 2008 and have the 192 recommendations on file time-stamped that we made since then ... 73 are open, and 119 were closed. We are in the 91st percentile on performance (defined as the average gain per recommendation versus the S&P-500), and 97th percentile on accuracy. With regards to our performance from 2003-2007, see picture on the right (from 2008). That award was for our four-year track record through December 31, 2007. Trailing three years, our (192) recommendations on average beat the S&P-500 by 541 basis points (each) and the average holding period per recommendation was just under seven months, so the annualized gain per recommendation versus the S&P has been more than nine percentage points (900 bps).
Top 15 (out of 191)
----------------------------------
001 - Edward Owens 98.93
002 - Einhorn 98.55
003 - Benchmark 98.32
004 - SMH Capital 98.29
005 - Feltland 98.17
006 - Rich Aster 98.13
007 - Standpoint Research 96.37
008 - Bank of America 96.19
009 - Wunderlich 96.11
010 - KeyBanc 95.75
011 - Eveillard 95.73
012 - Davenport 95.31
013 - Soleil 95.04
014 - Hilliard 95.01
015 - Stifel Nicolaus 94.91
------------------------------------
Notables
------------------------------------
033 - Credit Suisse 92.84
036 - Citigroup 92.64
038 - Bernstein 92.34
041 - George Soros 92.17
049 - Longbow 91.33
065 - Piper Jaffray 88.58
069 - Thomas Weisel 87.96
093 - Needham 81.88
117 - Zacks 71.83
119 - Goldman Sachs 71.13
123 - Collins Stewart 67.48
132 - Merriman 59.54
139 - Brean Murray 51.04
152 - Rich Pzena 36.12
163 - Dahlman Rose 25.73
We have issued more than 400 recommendations since July 1, 2003. We have beaten the S&P-500 for seven years out of eight and are ahead of the S&P benchmark by more than 4000 basis points (since July 1, 2003). We did this with annual turnover of 50%-100%, without taking big sector bets, and with a diversified, relatively low-beta portfolio of mid-cap and large cap stocks. On a risk-adjusted basis, our performance has been extraordinary. Turnover is a function of market volatility and was higher for us in 2008-2011 than it was in 2003-2007.
|
A track record document for the years 2003-2007 and a table tracking our most recent (200) recommendations from the October 15, 2008 through September 15, 2011 period, is on our Performance page.
|
|
| Latest News |
|
|
|
|
|
|
|
|
| Standpoint in the Media |
|
Click on the link below for
Standpoint Research CEO, Ronnie
Moas’ appearance on Canada’s
Business News Network…
Click Here
|
For benzinga.com interview
with Ronnie Moas Click Here
Benzinga is a financial web site
Receiving 100,000 visitors daily.
|
Click on the link below for
Standpoint Research CEO, Ronnie
Moas’ appearance on Bloomberg
Radio program Taking Stock with
Pimm Fox (11 minutes). Click the
link for March 10, 2010 and fast fwd
49 minutes into the program.
Click Here
|
|
| |

Standpoint Research is on the
Integrity Research Associates platform.
IRA (LLC) is an information and solutions
provider specializing in the investment
research industry. Its institutional investor
clients use Integrity's services to find new
research providers and monitor existing ones.
|
| |
| |
 |
Standpoint Research, Inc. is a member of
the Investorside Research Association; a
Washington D.C. based non-profit organization.
Investorside certifies that its members have
no investment banking or other conflicts. |
|
| |
|
|
|
| |
Standpoint Research
Flamingo South Beach
Center Tower
1504 Bay Road # 2210
Miami Beach, FL 33139
|
| |
For Institutional Clients
UBS, Barclays, Credit Suisse, Instinet &
Deutsche Bank are our preferred brokers for ‘soft’ dollar payments.
|
| |
We sell our research mainly to institutional clients … high net worth individuals are welcome to contact us. |
|
|
Equity Research &
Portfolio Diagnostics |
|
| Standpoint Research provides independent equity
research that is free from the conflicts of asset
management, investment banking, proprietary
trading, and fee-for-research arrangements. We
provide thorough analysis, diagnostics and
forecasts on
domestic and international equities
and markets backed by alpha-generating
variables back-tested on many years of data. Standpoint Research currently advises and sells its research to pension funds, hedge funds and asset management firms. Wall Street analysts have an optimistic bias, while we are more objective. In fact some of the variables in our model that are looked at as positives by Wall Street actually carry negative weight in our model.
We have a strict discipline
that includes running our proprietary 155-variable
valuation and
diagnostics model with a personal
and subjective overlay that has been proven to add
value. The effectiveness is demonstrated through
our impressive eight-year track record of more than 400
recommendations. |
| More... |
 |
|
Ronnie Moas (CEO, Standpoint Research) receiving an award
from Patrick Shea (Executive Director, Investorside Research Association).
Standpoint is now widely recognized as one of the top equity research
firms in the U.S. and Internationally. Ronnie has made multiple appearances
on Bloomberg, and has been quoted in The Wall St. Journal,The New York Times,
BusinessWeek and Barron’s. Ronnie, shown above on the right side, founded Standpoint Research
in 2003 after spending several years developing a proprietary 155-variable valuation and
diagnostic model to assist him in generating equity investment recommendations.
In addition to his quantitative model, Ronnie and his team also use proven fundamental
and subjective overlays in their research before issuing a recommendation.
|
| |
| Report Schedule * |
|
|
Sep 02: ADR / International-160 _ # 786
Sep 06: Discretionary-300 _ # 787
Sep 09: Individual write-up MDT _ # 788 *
Sep 13: Industrials-240 _ # 789
Sep 16: Technology-300 _ # 790
Sep 20: Energy-150 _ # 791
Sep 24: Individual write-up BLK _ # 792 *
Sep 28: Short Interest-1000 _ # 793
|
| ................................................... |
|
Oct 04: Utilities-100 _ # 794
Oct 07: S&P-500 _ # 795
Oct 11: High-Dividends-200 _ # 796
Oct 14: Individual write-up SI_ # 797 *
Oct 17: Russell-1000 _ # 798
Oct 20: Russell-2000 _ # 799
Oct 24: Individual write-up TBD _ # 800
Oct 27: Financials-180 _ # 801
|
| ................................................... |
|
Nov 01: Materials-100 _ # 802
Nov 04: S&P-1500 _ # 803
Nov 08: Individual write-up TBD _ # 804
Nov 10: Staples-100 _ # 805
Nov 14: Russell-3000 _ # 806
Nov 26: Individual write-up TBD _ # 807
Nov 28: Telecom-100 _ # 808
Nov 30: Healthcare-180 _ # 809
|
|
| ................................................... |
|
Dec 02: ADR / International-160 _ # 810
Dec 05: Discretionary-300 _ # 811
Dec 09: Individual write-up TBD _ # 812
Dec 14: Industrials-240 _ # 813
Dec 17: Technology-300 _ # 814
Dec 22: Energy-150 _ # 815
Dec 27: Individual write-up TBD _ # 816
Dec 29: Short Interest-1000 _ # 817
|
| |
|
|
|
*Our individual write-ups are ~ 10-14 pages in length and cover the recommended stock, its industry and competitors. If you missed any reports, they can be re-sent on request. The recommendation date for (both) MDT and BLK was 15-Aug-11; for SI it was 12-Sept-11.
|
|
|
|